AU2015314934A1 - Peptide microarrays and novel biomarkers for celiac disease - Google Patents

Peptide microarrays and novel biomarkers for celiac disease Download PDF

Info

Publication number
AU2015314934A1
AU2015314934A1 AU2015314934A AU2015314934A AU2015314934A1 AU 2015314934 A1 AU2015314934 A1 AU 2015314934A1 AU 2015314934 A AU2015314934 A AU 2015314934A AU 2015314934 A AU2015314934 A AU 2015314934A AU 2015314934 A1 AU2015314934 A1 AU 2015314934A1
Authority
AU
Australia
Prior art keywords
peptide
array
polypeptide
amino acids
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015314934A
Other languages
English (en)
Inventor
Kang BEI
Vasanth JAYARAMAN
Karthik Krishna
Hari Krishnan KRISHNAMURTHY
John J. Rajasekaran
Tianhao WANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vibrant Holdings LLC
Original Assignee
Vibrant Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vibrant Holdings LLC filed Critical Vibrant Holdings LLC
Publication of AU2015314934A1 publication Critical patent/AU2015314934A1/en
Priority to AU2019200921A priority Critical patent/AU2019200921B2/en
Priority to AU2021203987A priority patent/AU2021203987A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2015314934A 2014-09-10 2015-09-10 Peptide microarrays and novel biomarkers for celiac disease Abandoned AU2015314934A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2019200921A AU2019200921B2 (en) 2014-09-10 2019-02-08 Peptide microarrays and novel biomarkers for celiac disease
AU2021203987A AU2021203987A1 (en) 2014-09-10 2021-06-16 Peptide microarrays and novel biomarkers for celiac disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462048537P 2014-09-10 2014-09-10
US62/048,537 2014-09-10
PCT/US2015/049528 WO2016040703A1 (en) 2014-09-10 2015-09-10 Peptide microarrays and novel biomarkers for celiac disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019200921A Division AU2019200921B2 (en) 2014-09-10 2019-02-08 Peptide microarrays and novel biomarkers for celiac disease

Publications (1)

Publication Number Publication Date
AU2015314934A1 true AU2015314934A1 (en) 2017-04-20

Family

ID=55459587

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2015314934A Abandoned AU2015314934A1 (en) 2014-09-10 2015-09-10 Peptide microarrays and novel biomarkers for celiac disease
AU2019200921A Active AU2019200921B2 (en) 2014-09-10 2019-02-08 Peptide microarrays and novel biomarkers for celiac disease
AU2021203987A Abandoned AU2021203987A1 (en) 2014-09-10 2021-06-16 Peptide microarrays and novel biomarkers for celiac disease

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2019200921A Active AU2019200921B2 (en) 2014-09-10 2019-02-08 Peptide microarrays and novel biomarkers for celiac disease
AU2021203987A Abandoned AU2021203987A1 (en) 2014-09-10 2021-06-16 Peptide microarrays and novel biomarkers for celiac disease

Country Status (7)

Country Link
US (2) US10900964B2 (enExample)
EP (1) EP3191629A4 (enExample)
JP (3) JP6887945B2 (enExample)
AU (3) AU2015314934A1 (enExample)
CA (1) CA2960655C (enExample)
NZ (1) NZ730519A (enExample)
WO (1) WO2016040703A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015314934A1 (en) 2014-09-10 2017-04-20 Vibrant Holdings, Llc Peptide microarrays and novel biomarkers for celiac disease
CA3000509C (en) 2015-10-29 2021-07-27 Vibrant Holdings, Llc Methods, tools, and tool assemblies for biomolecular analysis using microarrays
WO2017223116A2 (en) * 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
CN109790203A (zh) * 2016-06-20 2019-05-21 健康之语公司 自身免疫疾病的诊断和治疗方法
JP6872024B2 (ja) 2016-10-04 2021-05-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 合成分類指標の同定のためのシステムおよび方法
CN110168370A (zh) 2016-11-11 2019-08-23 健康之语公司 用于鉴定候选生物标志物的方法
CN107176974B (zh) * 2017-06-06 2021-04-13 中国医学科学院北京协和医院 ω-5-醇溶蛋白特异的CD4+T细胞表位及其应用
US20200384436A1 (en) * 2018-01-05 2020-12-10 Centrillion Technologies, Inc. Methods for fabricating high resolution dna array and its application in sequencing
US20210341493A1 (en) * 2018-10-08 2021-11-04 Vibrant Holdings Llc tTG-DGP BIOMARKERS FOR MONITORING CELIAC DISEASE
CN111926051A (zh) * 2020-07-10 2020-11-13 内蒙古燕谷坊全谷物产业发展有限责任公司 一种燕麦肽粉及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630557C2 (de) 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
EP1197755A1 (en) 2000-10-11 2002-04-17 Pepscan Systems B.V. Identification of protein binding sites
US20020086319A1 (en) 2000-11-13 2002-07-04 Ellson Richard N. Integrated device with surface-attached molecular moieties and related machine-readable information
JP2002320341A (ja) 2001-02-14 2002-10-31 Sony Corp 充放電装置および方法、電力供給装置および方法、電力供給システムおよび方法、プログラム格納媒体、並びにプログラム
ATE509272T1 (de) 2001-11-09 2011-05-15 3Dbiosurfaces Technologies Llc Substrate mit hochliegendem oberflächenbereich für mikroarrays sowie verfahren zur herstellung davon
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
US7290169B2 (en) 2004-04-06 2007-10-30 Hewlett-Packard Development Company, L.P. Core-level processor lockstepping
CA2732108A1 (en) 2008-07-28 2010-02-04 Children's Medical Center Corporation Prominin-1 peptide fragments and uses thereof
PT2367561E (pt) * 2008-11-30 2015-10-23 Immusant Inc Composições e métodos para o tratamento da doença celíaca
FR2949782B1 (fr) 2009-09-04 2015-10-16 Isp Investments Inc Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
CA3191015A1 (en) 2012-02-07 2013-08-15 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
DE102013214247A1 (de) 2013-07-22 2015-01-22 Bayerische Motoren Werke Aktiengesellschaft Blindnietmutter für die Verbindung zweier Bauteile
CN103675291A (zh) 2013-11-25 2014-03-26 南昌大学 一种基于t细胞表位筛查低乳糜泻毒性小麦品种的方法
AU2015314934A1 (en) 2014-09-10 2017-04-20 Vibrant Holdings, Llc Peptide microarrays and novel biomarkers for celiac disease

Also Published As

Publication number Publication date
NZ730519A (en) 2018-10-26
CA2960655A1 (en) 2016-03-17
JP7256229B2 (ja) 2023-04-11
AU2021203987A1 (en) 2021-07-08
US20210285948A1 (en) 2021-09-16
US20170269077A1 (en) 2017-09-21
NZ742911A (en) 2024-02-23
EP3191629A4 (en) 2018-07-11
JP2023093494A (ja) 2023-07-04
EP3191629A1 (en) 2017-07-19
CA2960655C (en) 2024-03-19
JP2021144040A (ja) 2021-09-24
JP2017532544A (ja) 2017-11-02
AU2019200921B2 (en) 2021-07-01
WO2016040703A1 (en) 2016-03-17
US10900964B2 (en) 2021-01-26
AU2019200921A1 (en) 2019-03-07
JP6887945B2 (ja) 2021-06-16
JP7781813B2 (ja) 2025-12-08

Similar Documents

Publication Publication Date Title
JP7781813B2 (ja) セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー
US12454771B2 (en) Substrates, peptide arrays, and methods
DK2367561T3 (en) Configurations and methods for treatment of celiac
BR122013006960A2 (pt) Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo
PT2083856E (pt) Péptidos para a dessensibilização contra alergénios
CN103502515B (zh) 自身免疫疾病的抗原替代物
CN101282989A (zh) 用于诊断风湿性疾病的方法
JP7664838B2 (ja) セリアック病をモニタリングするためのｔＴＧ－ＤＧＰバイオマーカー
CA2925000A1 (en) Compositions and methods related to oat sensitivity

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted